Vera Therapeutics (NASDAQ:VERA) Shares Gap Down on Insider Selling

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report)’s share price gapped down before the market opened on Monday after an insider sold shares in the company. The stock had previously closed at $37.52, but opened at $36.63. Vera Therapeutics shares last traded at $37.81, with a volume of 45,552 shares traded. Specifically, Director Maha Katabi […]

Related Keywords

Canada ,Maha Katabi ,Raymond James ,Royal Bank ,Vera Therapeutics Inc ,Tower Research Capital ,Ameritas Investment Partners Inc ,Nasdaq ,Cantor Fitzgerald ,Vera Therapeutics Company Profile ,Vera Therapeutics ,Get Free Report ,Director Maha Katabi ,Research Capital ,Investment Partners ,Amalgamated Bank ,Vera Therapeutics Daily ,Nasdaq Vera ,Vera ,Medical ,Stocks ,Technicals ,